Intrexon Names Christopher Basta Vice President of Investor Relations

    Intrexon Names Christopher Basta Vice President of Investor Relations

PR Newswire

GERMANTOWN, Md., May 19, 2014

GERMANTOWN, Md., May 19, 2014 /PRNewswire/ --Intrexon Corporation (NYSE:
XON), a leader in synthetic biology, today announced the appointment of
Christopher Basta as Vice President of Investor Relations, effective
immediately. Mr. Basta will report directly to Chairman and Chief Executive
OfficerRandal J. Kirk.

Intrexon Corporation logo

Mr. Basta brings more than 18 years of financial experience to Intrexon. Most
recently, he was a consultant for DSP Group directing its investor relations
initiatives. Prior to his consulting work, Mr. Basta spent the majority of
his Wall Street career at Royal Bank of Canada, where over nine years he
helped establish its Middle Markets division and subsequently transitioned to
assist in the growth of its Institutional Equity Sales division. He left RBC
in 2011 to join GM Advisory Group as Managing Director and Portfolio Manager
for its internal hedge fund where he implemented various investment strategies
across both public securities and private equity. Mr. Basta also previously
served as Vice President at both Lehman Brothers and First Union. He earned a
B.S. in Communications from the State University of New York, Albany.

Mr. Kirk commented, "Chris has an integrated knowledge of capital markets and
strategic communications that make him an ideal addition to the Intrexon
team. He can clearly communicate the Intrexon investment thesis and
supportive facts, and he possesses a deep understanding of investors of many
types. We are excited to have Chris join our management team and believe he
will make an excellent addition as we continue to grow our business and drive
investor interest to create value for the Company and its shareholders."

Mr. Basta added, "The suite of proprietary technologies that Intrexon has
constructed over the past 16 years positions it at the forefront of the
synthetic biology industry, which has the potential to redefine many of the
world's health, food, energy, consumer and environmental challenges. The
Company's Exclusive Channel Collaboration model is unique in its ability to
capture the significant opportunity at hand in an extremely capital efficient
manner, and its equity ownership and royalty structure provide multiple paths
to deliver shareholder returns. I am pleased to join Intrexon's strong team
at this exciting time and look forward to working with current and future
shareholders."

About Intrexon Corporation
Intrexon Corporation(NYSE: XON) is a leader in synthetic biology focused on
collaborating with companies in Health, Food, Energy, Environment, and
Consumer Sectors to create biologically-based products that improve the
quality of life and the health of the planet. Through the company's
proprietary UltraVector^® platform, Intrexon provides its partners with
industrial-scale design and development of complex biological systems. The
UltraVector^® platform delivers unprecedented control over the quality,
function, and performance of living cells. We call our synthetic biology
approach and integrated technologies Better DNA®, and we invite you to
discover more at www.dna.com.

Safe Harbor Statement
Some of the statements made in this press release are forward-looking
statements that involve a number of risks and uncertainties and are made
pursuant to the Safe harbor Provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based upon
Intrexon's current expectations and projections about future events and
generally relate to Intrexon's plans, objectives and expectations for the
development of Intrexon's business. Although management believes that the
plans and objectives reflected in or suggested by these forward-looking
statements are reasonable, all forward-looking statements involve risks and
uncertainties and actual future results may be materially different from the
plans, objectives and expectations expressed in this press release. These
risks and uncertainties include, but are not limited to, (i) Intrexon's
current and future ECCs and joint ventures; (ii) developments concerning
Intrexon's collaborators; (iii) Intrexon's ability to successfully enter new
markets or develop additional products, whether with its collaborators or
independently; (iv) competition from existing technologies and products or new
technologies and products that may emerge; (v) actual or anticipated
variations in Intrexon's operating results; (vi) actual or anticipated
fluctuations in Intrexon's competitors' or its collaborators' operating
results or changes in their respective growth rates; (vii) Intrexon's cash
position; (viii) market conditions in Intrexon's industry; (ix) Intrexon's
ability, and the ability of its collaborators, to protect Intrexon's
intellectual property and other proprietary rights and technologies; (x)
Intrexon's ability, and the ability of its collaborators, to adapt to changes
in laws or regulations and policies; (xi) the ability of Intrexon's
collaborators to secure any necessary regulatory approvals to commercialize
any products developed under the ECCs; (xii) the rate and degree of market
acceptance of any products developed by a collaborator under an ECC; (xiii)
Intrexon's ability to retain and recruit key personnel; (xiv) Intrexon's
expectations related to the use of proceeds from its initial public offering;
(xv) Intrexon's estimates regarding expenses, future revenue, capital
requirements and needs for additional financing; and (xvi) Intrexon's
expectations relating to AquaBounty. For a discussion of other risks and
uncertainties, and other important factors, any of which could cause
Intrexon's actual results to differ from those contained in the
forward-looking statements, see the section entitled "Risk Factors" in
Intrexon's Annual Report on Form 10-K, as well as discussions of potential
risks, uncertainties, and other important factors in Intrexon's subsequent
filings with the Securities and Exchange Commission. All information in this
press release is as of the date of the release, and Intrexon undertakes no
duty to update this information unless required by law.

For more information regarding Intrexon Corporation, contact:

Corporate Contact:            Investor Contact:
Marie Rossi                   The Ruth Group
Corporate Communications      David Burke

Intrexon Corporation          Tel: +1 (646) 536-7009

Tel: +1 (301) 556-9850        dburke@theruthgroup.com

publicrelations@intrexon.com  

Logo - http://photos.prnewswire.com/prnh/20130919/NY83283LOGO

SOURCE Intrexon Corporation

Website: http://www.dna.com
 
Press spacebar to pause and continue. Press esc to stop.